Center for Scientific Review; Amended Notice of Meeting

---
identifier: "/us/fr/2024-22979"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2024-22979"
section_name: "Center for Scientific Review; Amended Notice of Meeting"
positive_law: false
currency: "2024-10-04"
last_updated: "2024-10-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2024-22979"
document_type: "notice"
publication_date: "2024-10-04"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "89 FR 80906"
fr_volume: 89
---


#  Center for Scientific Review; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the Cardiovascular and Respiratory Sciences Integrated Review Group, Therapeutic Development and Preclinical Studies Study Section, October 23, 2024, 08:00 a.m. to October 24, 2024, 07:00 p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015, which was published in the *Federal Register* on September 25, 2024, FR Doc. No. 2024-21898, 89 FR 78319.

This meeting is being amended to change the meeting format from a hybrid meeting (in-person and virtual) to in-person only. The meeting is closed to the public.

Dated: October 1, 2024.

Lauren A. Fleck,

Program Analyst, Office of Federal Advisory Committee Policy.